home / stock / mnmd / mnmd articles

MNMD Articles, Mind Medicine (MindMed) Inc. - From 03/27/24

Stock Information
Company Name: Mind Medicine (MindMed) Inc.
Stock Symbol: MNMD
Market: NASDAQ
Website: mindmed.co
Menu
MNMD MNMD Quote MNMD Short MNMD News MNMD Articles MNMD Message Board
Get MNMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow | Benzinga

Welcome to a new episode of the Benzinga Psychedelics Podcast where we’re joined by Robert Barrow, CEO of Mind Medicine (MindMed) (NASDAQ:MNM...
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metr...

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-exp...

MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds | Benzinga

Shortly following the news on FDA's "breakthrough therapy" designation and the 12-week clinical durability data on its LSD therapy for general...
S&P 500 Gains 1%; Kroger Earnings Top Views | Benzinga

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow traded up 0.34% to 38,7...

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-q...

MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials | Benzinga

Mind Medicine (MindMed) (NASDAQ:MNMD) announced that the FDA has granted the "breakthrough therapy" designation to its MM120 (lysergide d-tartrate)...
What's Going On With MindMed Stock Thursday? | Benzinga

Mind Medicine Inc (NASDAQ:MNMD) shares are trading higher Thursday after the company received FDA breakthrough therapy designation and announced po...

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More | Benzinga

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned ...

MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued | Benzinga

Earlier this week, biopharma company Mind Medicine (MindMed) (NASDAQ: MNMD) released latest clinical trial results on repeated sub-perceptual doses...
Previous 10 Next 10